Triglycerides Test · Blood

Your triglyceride level is one of the fastest-moving numbers on a standard blood panel, and that volatility is both its strength and its trap. When triglycerides stay persistently elevated, they signal that your body is struggling to clear fat from the bloodstream, a problem tightly linked to insulin resistance, fatty liver, and cardiovascular disease. But because a single reading can swing by 20% or more from week to week, misreading one result can send you chasing a problem that does not exist, or ignoring one that does.

Triglycerides are the most calorie-dense form of stored energy in your body. They are assembled from three fatty acid chains attached to a glycerol backbone and travel through the blood inside lipoprotein particles. Your body loads them into these particles through two routes: the gut packages dietary fat into large particles called chylomicrons after you eat, and the liver builds its own fat-carrying particles (called VLDL) from fatty acids, glucose, and amino acids. What your triglyceride number actually reflects is the balance between how fast these particles are produced and how quickly your body clears them.

Heart Disease Risk

Elevated triglycerides have been tied to heart attack and cardiovascular death in some of the largest studies ever conducted. A meta-analysis pooling 61 prospective studies with over 726,000 participants found that people with triglycerides at or above 200 mg/dL had about 25% higher risk of dying from cardiovascular disease and 20% higher risk of dying from any cause compared to those with levels between 90 and 149 mg/dL. Each increase of roughly 88 mg/dL in triglycerides raised cardiovascular death risk by 13%.

The Copenhagen studies, which followed tens of thousands of Danish adults for up to 33 years, found even more dramatic risk gradients. People with nonfasting triglycerides around 580 mg/dL were about 5 times as likely to have a heart attack and about 3 times as likely to develop ischemic heart disease compared to those with levels around 70 mg/dL. Women appeared especially vulnerable: those with triglycerides at or above 443 mg/dL had roughly 4 times the risk of ischemic stroke.

There is an important caveat. When researchers adjust for HDL cholesterol and non-HDL cholesterol (a calculated number that captures all the "bad" cholesterol fractions), the independent contribution of triglycerides to heart disease risk often shrinks to near zero. A large Emerging Risk Factors Collaboration analysis of over 300,000 individuals found the association became nonsignificant after this adjustment. This suggests that what actually damages arteries may be the cholesterol-laden remnant particles that travel alongside triglycerides, rather than the triglycerides themselves. Your triglyceride number, in other words, is a signal flare for atherogenic (artery-damaging) particles in the blood, even if it is not the direct cause of plaque buildup.

Pancreatitis Risk

The most immediately dangerous consequence of very high triglycerides is acute pancreatitis, an inflammatory attack on the pancreas that can be life-threatening. The risk rises steeply with triglyceride level. In a study of over 116,000 people followed for about 7 years, even mildly elevated nonfasting triglycerides (89 to 176 mg/dL) were associated with about 60% higher pancreatitis risk compared to levels below 89 mg/dL. At levels above 443 mg/dL, the risk jumped to roughly 9 times higher.

The annual pancreatitis rate reaches about 5% at levels above 1,000 mg/dL and can climb to 20% when levels exceed 2,000 mg/dL. Patients with triglyceride-driven pancreatitis also tend to have worse outcomes, including more organ failure, more pancreatic tissue death, and longer hospital stays. This is why guidelines shift the treatment priority at very high levels: above 1,000 mg/dL, preventing pancreatitis takes precedence over cardiovascular risk reduction.

Type 2 Diabetes

Elevated triglycerides are one of the earliest measurable signals that your body is becoming resistant to insulin, often appearing years before blood sugar itself rises. A systematic review and meta-analysis of 101 studies found that people with high triglycerides had about 73% higher risk of developing type 2 diabetes. The risk was dose-dependent: triglycerides between roughly 150 and 200 mg/dL carried 42% higher risk, while levels above 200 mg/dL carried 82% higher risk compared to people with normal levels.

A study of over 1.8 million young adults aged 20 to 39 reinforced this pattern. Those with sustained high triglycerides over multiple measurements had nearly 4 times the risk of developing diabetes compared to those whose levels stayed consistently normal. The cumulative exposure mattered: the more readings that came back elevated, the higher the risk climbed. This makes triglycerides a useful early warning system for metabolic trouble, especially in younger adults who might not yet qualify for glucose-focused screening.

Kidney Function

Triglycerides appear to affect kidney health independently of other metabolic risk factors. In a massive US Veterans cohort of over 1.6 million patients, elevated triglycerides at or above 240 mg/dL were linked to faster progression toward kidney failure across all stages of chronic kidney disease. An Italian study of about 45,000 subjects found that even moderate hypertriglyceridemia (high triglycerides) (150 to 500 mg/dL) was associated with 48% increased risk of significant kidney function decline or end-stage kidney disease. Each 50 mg/dL increase in triglycerides pushed the risk modestly but measurably higher.

Reference Ranges

Because triglycerides are one of the most variable biomarkers on a standard lipid panel, with a biological coefficient of variation (a measure of how much the number naturally fluctuates from test to test) between 18% and 28%, the exact number on a single report deserves less weight than the trend over multiple readings. That said, every number needs a framework. The following tiers are drawn from the major U.S. guidelines, including the 2026 ACC/AHA Dyslipidemia Guidelines and the American Heart Association.

These cutpoints do not change by age, sex, or ethnicity in the current guidelines, even though average levels vary substantially across these groups. Mexican American men aged 50 to 59 have a nearly 59% prevalence of levels at or above 150 mg/dL, while African Americans tend to have inherently lower levels. Your lab may use slightly different assays and cutpoints. Compare your results within the same lab over time for the most meaningful trend.

Hidden Cholesterol Risk: Why Your LDL Might Look Better Than It Is

One of the most consequential and least understood effects of elevated triglycerides is that they can make your LDL cholesterol reading misleadingly low. On a standard lipid panel, LDL cholesterol is not directly measured; it is calculated from your total cholesterol, HDL cholesterol, and triglycerides. The traditional formula used to do this (the Friedewald equation) systematically underestimates LDL when triglycerides are elevated. In one large analysis, patients with triglycerides between 150 and 199 mg/dL who appeared to be at their LDL goal were frequently reclassified as not at goal when LDL was directly measured.

This means that if your triglycerides are elevated, your "normal" LDL number may be hiding real risk. Non-HDL cholesterol, which is simply your total cholesterol minus your HDL cholesterol, sidesteps this problem entirely. It captures all the artery-damaging particles in your blood, including the triglyceride-rich remnants that the LDL calculation misses. If your triglycerides are persistently above 150 mg/dL, non-HDL cholesterol gives you a more reliable picture of your actual cardiovascular risk than LDL alone.

Subclinical Atherosclerosis

Triglycerides are not just a risk factor for future events; they correlate with arterial plaque that is already building up. In the PESA study of apparently healthy individuals, triglycerides at or above 150 mg/dL were independently associated with subclinical atherosclerosis (plaque detectable on imaging but not yet causing symptoms), even in people whose LDL cholesterol was normal. This finding reinforces the idea that triglyceride-rich particles contribute to plaque formation through a pathway that LDL alone does not capture.

Tracking Your Trend

Triglycerides have one of the highest day-to-day swings of any routine blood test. A single fasting measurement of 200 mg/dL could represent a true steady-state level anywhere from about 124 to 323 mg/dL, a range wide enough to span "normal" to "high" in a single person. This biological variability, which runs between 18% and 28% depending on the study, means that a single reading is a snapshot with a wide margin of error.

The American Heart Association recommends averaging three fasting samples drawn at least one week apart within a two-month window to get a reliable baseline. Research shows that three measurements narrow the uncertainty to roughly plus or minus 11%. Beyond the baseline, tracking your trend over time is far more informative than obsessing over any one number. If your triglycerides are dropping after dietary changes or exercise, you are seeing real biological improvement even if the absolute number has not yet crossed a guideline threshold.

Get a baseline, then retest in 3 to 6 months if you are making changes. Once stable, check at least annually. If you are on medication for high triglycerides or managing conditions like diabetes or kidney disease, your doctor may recommend more frequent monitoring.

When Results Can Be Misleading

The most common reason for a misleading triglyceride result is not fasting long enough before the draw. After a typical meal, triglycerides rise by an average of about 26 mg/dL, peaking 3 to 4 hours after eating. A high-fat meal can push levels more than 50% above fasting values. For initial screening, nonfasting samples are generally fine, but if your nonfasting result comes back above 175 mg/dL, a fasting confirmation (8 to 12 hours without food) is worth doing before drawing conclusions.

Triglycerides also have a circadian rhythm (a natural daily cycle), peaking in the afternoon and evening. If you are tracking trends over time, try to get your blood drawn at the same time of day. There is even a weekday effect: levels tend to be about 4.5% lower on Fridays than Mondays, likely reflecting weekend dietary patterns.

A single bout of moderate exercise (30 to 60 minutes) can lower your postprandial (after-meal) triglyceride response by 15 to 30% for up to 48 hours afterward. If you exercise the day before a blood draw, your reading may look better than your typical baseline. Acute illness, particularly infections and sepsis, can spike triglycerides significantly by impairing the enzymes that clear fat from the blood. If your lipids were drawn during a hospitalization or while you were sick, retest once you have recovered.

Several common medications can elevate triglycerides as a side effect without indicating metabolic disease. Beta-blockers (especially atenolol, metoprolol, and propranolol), thiazide and loop diuretics, corticosteroids, oral estrogens, atypical antipsychotics (particularly olanzapine and clozapine), bile acid sequestrants, isotretinoin, HIV protease inhibitors, and immunosuppressants (tacrolimus, sirolimus, cyclosporine) can all raise levels. If you are taking any of these, your triglyceride result may not reflect your underlying metabolic health.